Markers of epithelial-mesenchymal transformation in the placenta and amniotic membranes by chorioamnionitis
DOI:
https://doi.org/10.15574/HW.2025.1(176).3337Keywords:
premature rupture of membranes, chorioamnionitis, epithelial-mesenchymal transformation, cytokeratin, vimentin, amniotic glucose concentrationAbstract
Premature rupture of membranes (PROM) is a significant problem in obstetric practice, causing significant complications for both the mother and the fetus.
Aim - to study the prevalence of markers of epithelial-mesenchymal transformation (EMT) in placentas from women with PROM depending on the level of glucose in the amniotic fluid and gestational age.
Materials and methods. A study was conducted on the placentas of 40 women, which, depending on the gestational age and the determined amniotic glucose concentration, were divided into groups: I group - 10 placentas from births at 24-37 weeks against the background of amniotic glucose concentration <0.5 mmol/l, II group - 10 placentas from births at 24-37 weeks by amniotic glucose concentration ≥0.5 mmol/l, III group - 10 placentas from term births with amniotic glucose concentration <0.5 mmol/l, IV group - 10 placentas from term by amniotic glucose concentration ≥0.5 mmol/l. In all placentas the content of vimentin and cytokeratin in the amnion and decidual membrane was determined by immunohistochemical method.
Results. In the II group cytokeratin expression was 0.178±0.006 c.u., which was significantly higher compared to the I group (0.156±0.007 c.u), in full-term pregnancies - 0.186±0.007 c.u and 0.138±0.005 c.u in the III group and the IV group respectively. In the I group vimentin expression was 0.267±0.004 c.u, but in the I group decreased to 0.178±0.003 c.u, in full-term pregnancies vimentin was also lower in the III group (0.138±0.006 c.u) compared to the IV group (0.207±0.005 c.u). This pattern indicates that low glucose levels suppress mesenchymal activity of chorionic villus cells
Conclusions. Chorioamnionitis as a complication of PROM is accompanied by significant structural rearrangements of placental tissues and amniotic membranes, which is manifested by a decrease in the expression of cytokeratin (a marker of epithelial cells) and an increase in the level of vimentin (a mesenchymal marker). This indicates a weakening of epithelial properties and activation of mesenchymal transformation. A clear dependence of the level of cytokeratin and vimentin expression on the glucose concentration in the amniotic fluid and gestational age was revealed: in the groups with low glucose levels (<0.5 mmol/l) a significant decrease in cytokeratin was observed, indicating a loss of epithelial cell integrity. An increase in vimentin levels at low glucose levels is associated with EMT activation, structural destabilization of membranes and an increased risk of their rupture.
The study was conducted in accordance with principles of the Declaration of Helsinki. Research protocol was approved by local ethics committee of the participating institution. Informed consent was obtained.
The authors declare no conflict of interest.
References
Bila VV, Zahorodnia OS. (2024). Correlation of markers of maternal and fetal inflammation. Ukrainian Journal Health of Woman. 3(172): 55-60. https://doi.org/10.15574/HW.2024.172.55
Choltus H, Lavergne M, De Sousa Do Outeiro C, Coste K, Belville C et al. (2021, Aug 31). Pathophysiological Implication of Pattern Recognition Receptors in Fetal Membranes Rupture: RAGE and NLRP Inflammasome. Biomedicines. 9(9): 1123. https://doi.org/10.3390/biomedicines9091123; PMid:34572309 PMCid:PMC8466405
Giouleka S, Tsakiridis I, Emmanouilidou G, Boureka E, Kalogiannidis I, Mamopoulos A et al. (2024, Oct). Diagnosis and Management of Preterm Prelabor Rupture of Membranes: A Comprehensive Review of Major Guidelines. Obstet Gynecol Surv. 79(10): 591-603. https://doi.org/10.1097/OGX.0000000000001313; PMid:39437377
Grill A, Goeral K, Leitich H, Farr A, Berger A, Rittenschober-Boehm J. (2024, May). Maternal biomarkers in predicting neonatal sepsis after preterm premature rupture of membranes in preterm infants. Acta Paediatr. 113(5): 962-972. https://doi.org/10.1111/apa.17114; PMid:38265123
Ji W, Li G, Jiang F, Zhang Y, Wu F, Zhang W et al. (2024, Jan). Preterm birth associated alterations in brain structure, cognitive functioning and behavior in children from the ABCD dataset. Psychol Med. 54(2): 409-418. https://doi.org/10.1017/S0033291723001757; PMid:37365781
Khatib N, Weiner E. (2022). Cytokeratin downregulation in premature rupture of membranes. European Journal of Obstetrics & Gynecology and Reproductive Biology. 271: 150-156.
Kumar D, Moore RM, Mercer BM, Mansour JM, Redline RW, Moore JJ. (2016, Jun). The physiology of fetal membrane weakening and rupture: Insights gained from the determination of physical properties revisited. Placenta. 42: 59-73. https://doi.org/10.1016/j.placenta.2016.03.015; PMid:27238715
Merello M, Lotte L, Gonfrier S, Eleni Dit Trolli S, Casagrande F et al. (2019, Mar). Enterobacteria vaginal colonization among patients with preterm premature rupture of membranes from 24 to 34 weeks of gestation and neonatal infection risk. J Gynecol Obstet Hum Reprod. 48(3): 187-191. https://doi.org/10.1016/j.jogoh.2018.12.007; PMid:30562580
Owen JC, Garrick SP, Peterson BM, Berger PJ, Nold MF et al. (2023). The role of interleukin-1 in perinatal inflammation and its impact on transitional circulation. Front Pediatr. 11: 1130013. https://doi.org/10.3389/fped.2023.1130013; PMid:36994431 PMCid:PMC10040554
Peng CC, Chang JH, Lin HY, Cheng PJ, Su BH. (2018, Jun). Intrauterine inflammation, infection, or both (Triple I): A new concept for chorioamnionitis. Pediatr Neonatol. 59(3): 231-237. https://doi.org/10.1016/j.pedneo.2017.09.001; PMid:29066072
Phillips A, Pagan M, Smith A, Whitham M, Magann EF. (2023). Management and Interventions in Previable and Periviable Preterm Premature Rupture of Membranes: A Review. Obstet Gynecol Surv. 78(11): 682-689. https://doi.org/10.1097/OGX.0000000000001198; PMid:38134338
Ronzoni S, D'Souza R, Shynlova O, Lye S, Murphy KE. (2019, Oct). Maternal blood endotoxin activity in pregnancies complicated by preterm premature rupture of membranes. J Matern Fetal Neonatal Med. 32(20): 3473-3479. https://doi.org/10.1080/14767058.2018.1465560; PMid:29656690
Tchirikov M, Schlabritz-Loutsevitch N, Maher J, Buchmann J, Naberezhnev Y et al. (2018, Jul 26). Mid-trimester preterm premature rupture of membranes (PPROM): etiology, diagnosis, classification, international recommendations of treatment options and outcome. J Perinat Med. 46(5): 465-488. https://doi.org/10.1515/jpm-2017-0027; PMid:28710882
Vanderhoeven JP, Bierle CJ, Kapur RP, McAdams RM, Beyer RP, Bammler TK et al. (2014, Mar 6). Group B streptococcal infection of the choriodecidua induces dysfunction of the cytokeratin network in amniotic epithelium: a pathway to membrane weakening. PLoS Pathog. 10(3): e1003920. https://doi.org/10.1371/journal.ppat.1003920; PMid:24603861 PMCid:PMC3946355
Vaughn JA, Goncalves LF, Cornejo P. (2022, Sep). Intrauterine and Perinatal Infections. Clin Perinatol. 49(3): 751-770. Epub 2022 Aug 22. https://doi.org/10.1016/j.clp.2022.05.008; PMid:36113933
Weed S, Armistead B, Coleman M, Liggit HD, Johnson B, Tsai J et al. (2020, Oct 13). MicroRNA Signature of Epithelial-Mesenchymal Transition in Group B Streptococcal Infection of the Placental Chorioamniotic Membranes. J Infect Dis. 222(10): 1713-1722. https://doi.org/10.1093/infdis/jiaa280; PMid:32453818 PMCid:PMC7751568
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ukrainian Journal Health of Woman

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.